Keck Medicine of USC is participating in a national, multisite clinical trial examining if a water vapor system that uses ...

Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney and bladder cancer, today ...

Francis Medical announced today that it has completed an oversubscribed $80 million Series C equity financing.

There were 143 patients who received hormonal therapy, with higher rates of ADT in salvage ablation (HR 1.42, 95% CI 0.97, 2.08, p = 0.068): Ongoing trials include the SAFE Pilot Trial of salvage ...

MRI-Guided Radiation Therapy Reduces Long-Term Side Effects for Patients With Prostate Cancer Nov. 13, 2024 — After a comprehensive two-year follow-up, researchers found that MRI-guided ...

This trial is comparing partial ablation treatment with radical treatment for prostate cancer. Read more about A trial looking at partial ablation treatment for prostate cancer (PART) A trial looking ...

AngioDynamics has obtained an FDA green light for its NanoKnife prostate cancer ablation system ... function-preserving treatment for men with prostate tumors,” AngioDynamics’ president ...

The aim of this study was to assess the precision and safety of targeted microwave ablation (TMA) using organ-based tracking (OBT) fusion, in patients with intermediate risk prostate cancer. We ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...

There is a wide variety of treatment options available for men with prostate cancer, including surgery, radiation therapy, hormone therapy and chemotherapy, any or all of which might be used at ...